Delivery Order V797P5025B-N0016813F0708

This federal contract award is for YTTRIUM 90 GLASS MICROSPHERES, which are used in interventional radiology procedures for cancer treatment. The prime contractor is Biocompatibles, Inc., a division of Boston Scientific Corp that develops minimally invasive medical devices. The contract was awarded by the Department of the Army Medical Command and has a firm fixed price value of $1,924,500.00. The contract does not have a set-aside designation. Biocompatibles, Inc. has previously fulfilled...

This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Biocompatibles, Inc., a division of Boston Scientific Corp. The $166,000.00 firm fixed price contract is for the provision of Yttrium-90 (Y-90) TheraSpheres, a type of therapeutic radiopharmaceutical used in interventional radiology procedures to treat liver cancer. The award represents an option year renewal of a previous contract, with a completion date of February 11, 2022....

The U.S. Department of the Army Medical Command awarded a sole source Firm-Fixed-Price contract to Boston Scientific Corp., doing business as Boston Scientific, for the procurement of Yttrium 90, a liver cancer therapy, for the Interventional Department of Radiology at Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, TX. The contract is valued at $420,000.00 and has an ultimate completion date of September 30, 2025. This contract was awarded without the use of a set-aside and...

This is a contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Biocompatibles, Inc., a division of Boston Scientific Corporation, to provide Yttrium-90 (Y90) TheraSphere glass microspheres. The Firm Fixed Price delivery order contract, valued at $208,000.00, is for the provision of this radiopharmaceutical product used in interventional radiology procedures for cancer treatment. The contract does not have a set-aside designation and was awarded on October...

The Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract worth $273,500.00 to Biocompatibles, Inc., a division of Boston Scientific Corporation, for the supply of Yttrium-90 (Y90) TheraSphere glass microspheres used to treat liver cancer. This contract is part of the VA's Veterans Health Administration program, which provides medical solutions and technologies to VA healthcare networks across the United States. Biocompatibles, a manufacturer of medical devices...

This federal contract award, valued at $672,000.00, was issued by the Department of Veterans Affairs (VA) to Biocompatibles, Inc., a division of Boston Scientific Corporation. The contract is for the delivery of radiopharmaceuticals, specifically Yttrium-90 (Y90) microsphere products, to VA hospitals and healthcare networks. Biocompatibles, a manufacturer of medical devices and provider of minimally invasive solutions, has fulfilled similar prime contracts with the VA for these therapeutic...

This federal contract award, valued at $314,322.29, is a delivery order issued by the U.S. Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company, a global biopharmaceutical firm. The contract is for the supply of IDECABTAGENE VICLEUCEL/ABECMA INJECTION, a chimeric antigen receptor (CAR) T-cell therapy used to treat certain types of cancer. The award is not designated as a set-aside contract. It is part of a larger Federal Supply Schedule (FSS) contract (ID: 36F79724D0101) between...

This is a Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Sirtex Medical Inc., a for-profit medical device company. The contract is for the supply of Sir-Sphere microspheres containing Yttrium-90, a radioactive isotope used in selective internal radiation therapy to treat inoperable liver cancer in VA patients. The potential value of this BPA call is $480,000.00. Sirtex Medical has provided these specialized...

This firm fixed-price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Sirtex Medical Inc., a global healthcare company, to provide RESIN Y-90 MICROSPHERES with a potential value of $17,300.00. The microspheres, which contain the radioactive isotope Yttrium-90, are used in selective internal radiation therapy to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military...

The Department of Veterans Affairs (VA), Veterans Integrated Service Network 22 (VISN 22), awarded a firm-fixed-price purchase order to Boston Scientific Corp for the supply of radiopharmaceutical therapy/treatment for liver cancer and hepatocellular carcinoma (HCC) containing the radioactive isotope yttrium-90. The contract, valued at $573,155.00, is for the delivery of an estimated 36 units over a one-year period on an as-needed basis. This requirement was not set aside for small businesses....